Publication Name	World Journal of Cardiology
Manuscript ID	16952
Country	Oman

Received	2015-02-04 08:15
Peer-Review Started	2015-02-05 20:13
To Make the First Decision	2015-04-27 15:39
Return for Revision	2015-04-28 14:06
Revised	2015-05-21 15:48
Second Decision	2015-06-01 08:47
Accepted by Journal Editor-in-Chief	2015-06-02 04:28
Accepted by Company Editor-in-Chief	2015-06-11 15:53
Articles in Press	2015-06-11 15:53
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-08-14 19:19
Publish the Manuscript Online	2015-08-27 11:20

ISSN	1949-8462 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Editorial
Article Title	Glycated hemoglobin and its spinoffs: Cardiovascular disease markers or risk factors?
Manuscript Source	Invited Manuscript
All Author List	Jumana Saleh
Funding Agency and Grant Number
Corresponding Author	Dr. Jumana Saleh, Department of Biochemistry, College of Medicine and Health Sciences, Sultan Qaboos University, PO Box 35, Muscat 123, Oman. jumana@squ.edu.om
Key Words	Glycated hemoglobin; Glycoxidative stress; Advanced glycation end products; Atherosclerosis; Diabetes mellitus
Core Tip	Glycated hemoglobin is a useful marker for the diagnosis of diabetes progression. Many studies present glycated haemoglobin (HbA1C) as an independent predictor of cardiovascular risk in diabetics. Although haemoglobin (Hb) is a major circulating protein, limited information is available about the role of glycated Hb as such in the etiology of atherosclerosis. This editorial highlights potential mechanisms by which glycated hemoglobin may contribute, as a causative factor, to the progression of atherosclerosis in diabetics.
Publish Date	2015-08-27 11:20
Citation	Saleh J. Glycated hemoglobin and its spinoffs: Cardiovascular disease markers or risk factors? World J Cardiol 2015; 7(8): 449-453
URL	http://www.wjgnet.com/1949-8462/full/v7/i8/449.htm
DOI	http://dx.doi.org/10.4330/wjc.v7.i8.449

Full Article (PDF)	WJC-7-449.pdf
Full Article (Word)	WJC-7-449.doc
Manuscript File	16952-Review.doc
Answering Reviewers	16952-Answering reviewers.pdf
Audio Core Tip	16952-Audio core tip.wma
Conflict-of-Interest Disclosure Form	16952-Conflict-of-interest statement.pdf
Copyright License Agreement	16952-Copyright assignment.pdf
Peer-review Report	16952-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	16952-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	16952-Scientific misconduct check.pdf
Scientific Editor Work List	16952-Scientific editor work list.pdf